FGFR4-IN-20 (comp 11) is an orally active and selective FGFR4 inhibitor, demonstrating IC50 values of 19 nM against Huh7 cells and 36 nM for FGFR4 kinase. It is utilized in hepatocellular carcinoma research.
Formula:
C26H22Cl2N4O3
Target:
FGFR
* VAT and and shipping costs not included. Errors and price changes excepted
